Oct 26, 2026 01:45PM
Oct 26, 2026 08:51AM
Oct 26, 2026 07:06AM
Oct 23, 2026 07:01AM
Oct 23, 2026 07:00AM
Oct 22, 2026 04:05PM
Oct 22, 2026 04:05PM Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Oct 21, 2026 08:24AM
Oct 20, 2026 08:40AM
Oct 19, 2026 07:58AM
Oct 19, 2026 07:00AM
Oct 15, 2026 08:30AM
Oct 14, 2026 09:53AM
Oct 10, 2026 10:00AM Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Graba
Oct 8, 2026 08:56AM
Oct 8, 2026 08:00AM
Oct 8, 2026 08:00AM
Oct 6, 2026 11:53AM
Sep 22, 2026 08:14AM
Sep 16, 2026 09:17AM
Sep 10, 2026 03:57PM INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Aardvark Therapeutics, Inc. (AARD) to Contact Law Firm
Sep 10, 2026 08:21AM
Sep 1, 2026 08:24AM
Aug 31, 2026 08:44AM
Aug 27, 2026 08:50AM
Aug 11, 2026 04:53PM
May 15, 2026 07:53AM
May 15, 2026 03:35AM Morgan Stanley Downgrades Aardvark Therapeutics Inc (AARD) to Underweight
May 14, 2026 04:01PM
May 14, 2026 04:01PM
May 7, 2026 08:00AM
Mar 24, 2026 05:46PM
Mar 24, 2026 01:02PM
Mar 24, 2026 09:35AM
Mar 24, 2026 05:14AM Aardvark Therapeutics Inc (AARD) PT Lowered to $8 at B.Riley
Mar 23, 2026 04:05PM
Mar 2, 2026 07:29AM
Mar 2, 2026 02:53AM
Mar 2, 2026 02:38AM
Mar 2, 2026 02:38AM
Mar 2, 2026 12:41AM
Feb 27, 2026 04:05PM Aardvark Therapeutics pauses phase 3 trial due to cardiac safety signals
Feb 27, 2026 04:05PM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM
Dec 10, 2025 04:05PM
Dec 10, 2025 04:05PM
Nov 13, 2025 04:05PM
Nov 4, 2025 12:00PM Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
Oct 22, 2025 08:00AM

335,384 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All